134 results
8-K
EX-99.1
CSBR
Champions Oncology Inc
12 Mar 24
Champions Oncology Reports Quarterly Revenue of $12.0 Million
4:31pm
.
Research and development expense for the three-months ended January 31, 2024 was $2.2 million, a decrease of $1.0 million or 31.7%, compared to $3.2 … volume due to some operational inefficiencies.
Research and development expense for the nine-months ended January 31, 2024 was $7.5 million, a decrease
8-K
EX-99.1
CSBR
Champions Oncology Inc
12 Dec 23
Champions Oncology Reports Quarterly Revenue of $11.6 Million
4:14pm
October 31, 2022. The lower margin resulted from lower revenue against a generally unchanged cost base.
Research and development expense for the six … services
Research and development
Sales and marketing
General and administrative
Income (loss) from operations
Other loss
Loss before provision
8-K
EX-99.1
ypvll
13 Sep 23
Champions Oncology Reports Quarterly Revenue of $12.6 Million
4:00pm
8-K
EX-99.1
1s0indv shm5g1h
24 Jul 23
Champions Oncology Reports Quarterly Revenue of $13.1 Million
4:04pm
8-K
EX-99.1
skufynsmwqfa6r
13 Dec 22
Champions Oncology Reports Record Quarterly Revenue of $14.3 Million
4:01pm
8-K
EX-99.1
rz49ozpmikx1gy
8 Sep 22
Champions Oncology Reports Record Quarterly Revenue of $13.7 Million
3:59pm
8-K
EX-99.1
81aa8
21 Jul 22
Champions Oncology Reports Quarterly Revenue of $12.9 Million
3:59pm
8-K
EX-99.1
k9mocz9hgtxjwq te7n
15 Mar 22
Champions Oncology Reports Record Quarterly Revenue of $13.2 Million
4:31pm
8-K
EX-99.1
f1aem86fj
13 Dec 21
Champions Oncology Reports Record Quarterly Revenue of $11.8 Million
3:59pm
8-K
EX-99.1
5d0sgvzwki8jaks743hd
13 Sep 21
Champions Oncology Reports Record Quarterly Revenue of $11.3 Million
4:17pm